2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) can induce estrogenic action or inhibit estrogen-induced effects in various tissues because of aryl hydrocarbon receptor (AhR)-estrogen receptor (ER) cross-talk. In order to identify the biomarkers of TCDD endocrine disruption, we screened estrogen-responsive genes modified by TCDD exposure using specific cDNA microarrays spotted with estrogen-responsive genes. MCF-7 human breast carcinoma cells and RL95-2 human endometrial carcinoma cells were exposed to TCDD, and an analysis of their gene expression revealed 32 genes exhibiting a significant change. The mRNA expression levels of 27 genes were subsequently verified using real-time RT-PCR. Among these genes, bioinformatic analyses indicated that insulin-like growth factor-binding protein 5 (IGFBP5) gene expression might be influenced by estrogen status. In our animal experiments, IGFBP5 was also shown to be responsive to TCDD exposure in mouse fetuses in utero. These results suggest that TCDD affects the expression levels of a series of estrogen-responsive genes, and follow-up fetal studies in mice indicated that IGFBP5 is useful as a biomarker of TCDD activity.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.mce.2007.04.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Epigenetic Modulation of Estrogen Receptor Signaling in Ovarian Cancer.
Int J Mol Sci
December 2024
Department of Gynecology and Obstetrics, University Medical Center Regensburg, 93935 Regensburg, Germany.
Article Synopsis
- Ovarian cancer is a major cause of cancer-related deaths in women, with both genetic and epigenetic factors contributing to its development and progression.
- Estrogen signaling plays a significant role in ovarian cancer, involving estrogen receptors and their regulation of genes related to cell growth and death, influenced by epigenetic changes like histone modifications and DNA methylation.
- This review summarizes current knowledge on these epigenetic mechanisms and explores the potential of epigenetic therapies as treatment options for ovarian cancer.
Intrauterine administration of peripheral blood mononuclear cells helps manage recurrent implantation failure by normalizing dysregulated gene expression including estrogen-responsive genes in mice.
Cell Commun Signal
December 2024
Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-Cho, Sakyo, Kyoto, 606-8507, Japan.
Background: Intrauterine peripheral blood mononuclear cell (PBMC) therapy for recurrent implantation failure (RIF) has been reported to improve embryo implantation by acting on the endometrium. However, the exact mode of action of PBMC on the endometrium of patients with RIF remains unclear. In addition, the differences in the therapeutic effects of PBMC therapy with and without human chorionic gonadotropin (hCG) are unknown.
View Article and Find Full Text PDFPhosphorylation of Zearalenone Retains Its Toxicity.
J Agric Food Chem
November 2024
Département de Biomédecine vétérinaire, Faculté de Médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, Québec J2S 2M2, Canada.
Microbial biotransformation of Zearalenone (ZEN) is a promising deactivation approach. The residual toxicity and stability of Zearalenone-14-phosphate (ZEN-14-P) and Zearalenone-16-phosphate (ZEN-16-P), two novel microbial phosphorylation products of ZEN, remain unknown. We investigated the cytotoxicity, oxidative stress, proinflammatory, and estrogenic activity of phosphorylated ZENs using porcine intestinal cells, uterine explants, and human endometrial cells and traced their metabolic fate by liquid chromatography-tandem mass spectrometry (LC-MS)/MS analysis.
View Article and Find Full Text PDFEstrogen Regulates Mitochondrial Activity Through Inducing Brain-Derived Neurotrophic Factor Expression in Skeletal Muscle.
J Cell Physiol
January 2025
School of Biological Sciences, The University of Hong Kong, Hong Kong Special Administrative Region, China.
Estrogen is an essential hormone for the development and functional activities of reproductive organs. Recent studies showed that estrogen signaling is also an important regulator of lipid and glucose metabolism in a number of tissues, but the molecular mechanism is not fully understood. We report here that estrogen is a stimulator of brain-derived neurotrophic factor (BDNF) synthesis in the skeletal muscle.
View Article and Find Full Text PDFEstrogenic post-menopausal anti-osteoporotic mechanism of L.: Phytochemicals and network pharmacology approaches.
Heliyon
October 2024
Centre for Drug and Herbal Development, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, 50300, Kuala Lumpur, Malaysia.
Hormone replacement therapy is used to treat postmenopausal syndrome caused by estrogen deficiency, but it has been linked to an increased risk of breast cancer. In India, L. is traditionally used to treat menstrual problems; however, there is a lack of mechanistic evidence of its phytoestrogenicity.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!